Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    November 2017
  1. MITCHELL R, Hopcroft LEM, Baquero P, Allan EK, et al
    Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition.
    J Natl Cancer Inst. 2017 Nov 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. MORTON LM, Sampson JN, Armstrong GT, Chen TH, et al
    Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    April 2017
  3. ENGELS EA, Parsons R, Besson C, Morton LM, et al
    RE: The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    March 2017
  4. MOZESSOHN L, Earle C, Spaner D, Cheng SY, et al
    The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  5. MOZESSOHN L, Earle C, Spaner D, Cheng SY, et al
    The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study.
    J Natl Cancer Inst. 2017;109:1-9.
    PubMed     Text format     Abstract available


    January 2017
  6. GEBLER C, Lohoff T, Paszkowski-Rogacz M, Mircetic J, et al
    Inactivation of Cancer Mutations Utilizing CRISPR/Cas9.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


    July 2016
  7. PADULA WV, Larson RA, Dusetzina SB, Apperley JF, et al
    Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    April 2016
  8. BROWER V
    Adhesion Molecules, Stem Cells, and the Microenvironment in Acute Myeloid Leukemia.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  9. SHAIKH F, Dupuis LL, Alexander S, Gupta A, et al
    Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    February 2016
  10. SINHA G
    Bovine Leukemia Virus Possibly Linked to Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  11. BROWER V
    Deep Sequencing of Acute Myeloid Leukemia Reveals Driver Mutations and New Targets.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  12. TENG CJ, Hu YW, Chen SC, Yeh CM, et al
    Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    December 2015
  13. BROWER V
    Targeted Therapies Improve Outlook for Chronic Lymphocytic Leukemia.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


  14. SAMPSON JN, Wheeler WA, Yeager M, Panagiotou O, et al
    Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.
    J Natl Cancer Inst. 2015;107:djv279.
    PubMed     Text format     Abstract available


    November 2015
  15. RICKS D
    Scientists Journey Into Genomes Via CRISPR-Cas9.
    J Natl Cancer Inst. 2015;107:djv352.
    PubMed     Text format    


    January 2015
  16. YAMAZAKI J, Taby R, Jelinek J, Raynal NJ, et al
    Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: